Date:September 06, 2012

Jodi Muscal, MD

Jodi Muscal, M.D.Assistant Professor
Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

Phone: 832-822-4242
Fax: 832-825-4039

Dr. Jodi Muscal
Texas Children’s Cancer Center
1102 Bates St., Suite 1230.1
Houston, TX 77030


Dr. Jodi Muscal is a member of the Developmental Therapeutics Program / Phase I Team and Solid Tumor Team. Her translational research focuses on the pre-clinical development and clinical application of new and targeted drugs for the treatment of childhood cancers. She works with the research team to maximize curative therapy and minimize treatment related toxicity. In the laboratory, she is currently exploring multiple new agents for pediatric tumors including an aurora kinase inhibitor. She served as chair of the recently completed multi-institutional phase I clinical trial of vorinostat and bortezomib in children with solid tumors and brain tumors conducted through the Children’s Oncology Group.

Dr. Jodi Muscal is a member of the Developmental Therapeutics Program and the Solid Tumor Programs.


M.D., Temple University School of Medicine
Residency, Children’s Hospital of Pittsburgh
Fellowship, Baylor College of Medicine

Selected Memberships

Member, American Academy of Cancer Research (AACR)
Member, American Society for Clinical Oncology (ASCO)
Member, American Society for Pediatric Hematology/ Oncology (ASPHO)
Member, Children’s Oncology Group (COG)

Clinical Interests

Solid Tumors
New Drug Development

Research Interests

Pre-clinical development and clinical application new drugs
Maximizing curative therapy
Minimizing treatment-related toxicity
Aurora kinase inhibitor